LianBio (LIAN) News Today $0.43 +0.01 (+3.49%) As of 07/11/2025 Add Compare Share Share Headlines Stock AnalysisChartCompetitorsDividendFDA EventsInsider TradesSEC FilingsTrendsBuy This Stock LIAN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period MeiraGTx Holdings PLCMay 3, 2025 | marketwatch.comChina's Zeekr prices US IPO at top of range to raise $441 millionMay 10, 2024 | msn.comExclusive-China's Zeekr prices US IPO at top of range to raise $441 million, source saysMay 9, 2024 | msn.comWhy Is LianBio (LIAN) Stock Moving Today?March 15, 2024 | investorplace.comLianBio (NASDAQ:LIAN) Short Interest Down 33.5% in FebruaryMarch 14, 2024 | marketbeat.comLianBio (NASDAQ:LIAN) Sets New 52-Week High at $4.98March 14, 2024 | marketbeat.comLianBio (NASDAQ:LIAN) Sets New 52-Week High at $4.96March 8, 2024 | marketbeat.comLianBio (NASDAQ:LIAN) Sets New 12-Month High at $4.88March 1, 2024 | marketbeat.comLianBio Announces Voluntarily Delisting from NasdaqFebruary 28, 2024 | globenewswire.comWith No Cure In Sight, Drugs Firm LianBio Begins Exit StrategyFebruary 23, 2024 | seekingalpha.comLianBio (NASDAQ:LIAN) Sees Strong Trading VolumeFebruary 14, 2024 | marketbeat.comLianBio Announces Wind Down Of Operations, Workforce Reduction; Stock Up In Pre-MarketFebruary 13, 2024 | markets.businessinsider.comLianBio (NASDAQ:LIAN) Sets New 52-Week High at $4.88February 13, 2024 | marketbeat.comLianBio to Wind Down Operations, Declares Special DividendFebruary 13, 2024 | marketwatch.comLianBio Shares Gain After Co Announces Plans to Wind DownFebruary 13, 2024 | marketwatch.comLianBio Announces Completion of Strategic ReviewFebruary 13, 2024 | finance.yahoo.com131,641 Shares in LianBio (NASDAQ:LIAN) Acquired by Landscape Capital Management L.L.C.February 8, 2024 | marketbeat.comShort Interest in LianBio (NASDAQ:LIAN) Rises By 19.6%January 14, 2024 | marketbeat.comB of A Securities Downgrades LianBio: Here's What You Need To KnowJanuary 3, 2024 | markets.businessinsider.comLianBio (NASDAQ:LIAN) Lowered to Underperform at Bank of AmericaJanuary 3, 2024 | marketbeat.comNanobiotix Partner LianBio Assigns Its Development and Commercialization Rights for NBTXR3 in China and Other Asian MarketsDecember 26, 2023 | markets.businessinsider.comLianBio Enters into Agreement Assigning its Rights for NBTXR3 in China and Other Asian MarketsDecember 26, 2023 | finance.yahoo.comLianBio (NASDAQ:LIAN) Lowered to Hold at Jefferies Financial GroupDecember 22, 2023 | marketbeat.comInterest Is Growing for Smaller, More Speculative NamesDecember 20, 2023 | realmoney.thestreet.comLianBio Announces Departure of Chief Financial OfficerDecember 20, 2023 | finance.yahoo.comLianBio Names Stone as Interim CEO as Wang ResignsDecember 19, 2023 | marketwatch.comLianBio Announces Departure of Chief Executive OfficerDecember 19, 2023 | finance.yahoo.comLianBio’s Board of Directors Unanimously Determines not to Pursue Unsolicited Proposal from Concentra BiosciencesDecember 6, 2023 | finance.yahoo.comLianBio Confirms Receipt of Unsolicited Proposal from Concentra BiosciencesDecember 1, 2023 | finance.yahoo.comLianBio (LIAN) Reports Q3 2023 Financial Results: Strategic Review in Progress Amid Clinical ...November 14, 2023 | finance.yahoo.comLianBio Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 13, 2023 | finance.yahoo.comAll You Need to Know About LianBio Sponsored ADR (LIAN) Rating Upgrade to Strong BuyNovember 8, 2023 | finance.yahoo.comLianBio Announces Topline Results from Phase 3 LIBRA Trial of TP-03 in Chinese Patients with Demodex BlepharitisOctober 30, 2023 | finance.yahoo.comWhy LianBio Stock Is Shooting Through the Roof This WeekOctober 27, 2023 | fool.comLianBio Announces Presentation of Data from Phase 2a Study of Infigratinib in Patients with Gastric Cancer at ESMO Congress 2023October 25, 2023 | finance.yahoo.comRaymond James Maintains Outperform Rating for LianBio: Here's What You Need To KnowOctober 25, 2023 | markets.businessinsider.comLianBio Reaches Agreement With Bristol Myers Squibb For Mavacamten; Stock UpOctober 24, 2023 | markets.businessinsider.comLianBio Shares Soar Premarket on Strategic Review, End of Bristol PactOctober 24, 2023 | marketwatch.comWe're Not Very Worried About LianBio's (NASDAQ:LIAN) Cash Burn RateSeptember 8, 2023 | finance.yahoo.comLianBio Announces Results from Phase 3 EXPLORER-CN Trial of Mavacamten Presented at the European Society of Cardiology Congress and Simultaneous Publication in JAMA CardiologyAugust 28, 2023 | finance.yahoo.comLianBio Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateAugust 14, 2023 | finance.yahoo.comLianBio Announces First Patient Treated in Phase 1 Trial of SHP2 Inhibitor BBP-398 in Combination with Osimertinib in Patients with Non-Small Cell Lung Cancer with EGFR MutationsAugust 3, 2023 | finance.yahoo.comInstitutions own 21% of LianBio (NASDAQ:LIAN) shares but private equity firms control 54% of the companyJuly 29, 2023 | finance.yahoo.comLianBio Partner Tarsus Pharmaceuticals Announces U.S. FDA Approval of XDEMVY™ (lotilaner ophthalmic solution) 0.25% for the Treatment of Demodex BlepharitisJuly 26, 2023 | finance.yahoo.comLianBio Partner NANOBIOTIX Enters into License Agreement with Janssen for Radioenhancer NBTXR3, with LianBio Retaining Development and Commercialization Rights in Greater China, South Korea, Singapore and ThailandJuly 18, 2023 | finance.yahoo.comLianBio Announces Phase 3 EXPLORER-CN Data Accepted for Late-Breaking Presentation at the European Society of Cardiology Congress 2023July 17, 2023 | finance.yahoo.comLianBio Announces Clinical Supply Agreement with AstraZeneca in China to Evaluate BBP-398 in Combination with Osimertinib in Patients with Non-Small Cell Lung Cancer with EGFR MutationsJuly 12, 2023 | finance.yahoo.comLianBio (NASDAQ:LIAN) Short Interest Up 193.4% in JuneJune 30, 2023 | marketbeat.comLianBio Announces Marketing Approval of CAMZYOS® (mavacamten) in SingaporeJune 26, 2023 | finance.yahoo.com2 Stocks I'm Watching in a Market Supported by FOMO and Short SqueezesJune 12, 2023 | realmoney.thestreet.com Get LianBio News Delivered to You Automatically Sign up to receive the latest news and ratings for LIAN and its competitors with MarketBeat's FREE daily newsletter. Email Address LIAN Media Mentions By Week LIAN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LIAN News Sentiment▼0.000.99▲Average Medical News Sentiment LIAN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LIAN Articles This Week▼00▲LIAN Articles Average Week Get LianBio News Delivered to You Automatically Sign up to receive the latest news and ratings for LIAN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CTMX News OGI News VOR News PROK News VYGR News FDMT News PBYI News IPHA News DERM News DMAC News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LIAN) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LianBio Please log in to your account or sign up in order to add this asset to your watchlist. Share LianBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
